Skip to content
ppharmaranks
Menu

xadago

Xadago (Safinamide Mesylate) is a medication used to treat Parkinson Disease.

Safinamide Mesylate · by Mdd US

Not yet rated· sourced from the FDA label
Rated against independent regulatory sources·Last updated June 7, 2026·How we rate
Verified againstopenFDANIH DailyMedRxClass

Key facts

Active ingredient
Safinamide Mesylate
Form
Tablet
Strength
Safinamide Mesylate EQ 100MG Base · Safinamide Mesylate EQ 50MG Base
Type
Prescription (Rx)
Brand or generic
Brand-name
Manufacturer
Mdd US
FDA application
NDA207145

May treat (source: NIH RxClass)

Dosage forms

Tablet

The forms currently marketed in the U.S., per the FDA National Drug Code Directory.

Ways to save

Ask for the generic

Same active ingredient, far cheaper. Is there a generic? →

Request a 90-day supply

Bulk fills usually lower the per-dose price vs monthly refills.

Use copay cards

Manufacturer copay cards & patient-assistance programs — especially for brand drugs.

Compare alternatives

A same-class option may cost less. See alternatives →

Frequently asked questions

What does Xadago treat?
Xadago (Safinamide Mesylate) may be used to treat parkinson disease, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
Is there a coupon or discount for Xadago?
pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Xadago. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
Who makes Xadago?
Xadago is marketed by Mdd US. You can see Mdd US's full profile, rating, and other products on pharmaranks.
Is Xadago a brand-name or generic drug?
Xadago is a brand-name product with the active ingredient Safinamide Mesylate.
Is Xadago available over the counter?
No. Xadago is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
What forms does Xadago come in?
Xadago is currently marketed as tablet, per the FDA's National Drug Code Directory.
Is Xadago FDA-registered?
Xadago is on record with the U.S. FDA under application number NDA207145. You can verify this on its official FDA label.

Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.

What people report to the FDA about SAFINAMIDE MESYLATE

The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 53 reports naming SAFINAMIDE MESYLATE — the active ingredient in Xadago, and the FDA flagged 89% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:

  • dyskinesia7 reports
  • fall6 reports
  • infusion site induration6 reports
  • decreased appetite5 reports
  • fracture5 reports
  • hallucination5 reports
  • infusion site pain4 reports
  • loss of personal independence in daily activities4 reports

Read these as a signal, not a rate. A report does not mean SAFINAMIDE MESYLATE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.

Source: openFDA drug/event (FAERS), retrieved September 26, 2026.

Reviews

No reviews yet. Be the first to write one.

Write a review

Reviews are user opinions, not medical advice. Consult a licensed professional.

People also viewed

Compare Xadago head-to-head

Identify a pill by its imprint →Check a drug interaction →Drug recalls →

Browse medications A–Z

Research products from A to Z, compare independent ratings, and find alternatives.